These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9525837)

  • 21. Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.
    O'Brien FE; Clarke G; Fitzgerald P; Dinan TG; Griffin BT; Cryan JF
    Br J Pharmacol; 2012 Jun; 166(4):1333-43. PubMed ID: 22250926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier.
    Ohnishi T; Tamai I; Sakanaka K; Sakata A; Yamashima T; Yamashita J; Tsuji A
    Biochem Pharmacol; 1995 May; 49(10):1541-4. PubMed ID: 7763297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice.
    Zhao YL; Du J; Kanazawa H; Sugawara A; Takagi K; Kitaichi K; Tatsumi Y; Takagi K; Hasegawa T
    Eur J Pharmacol; 2002 Jun; 445(1-2):115-23. PubMed ID: 12065202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR; Burgess R; Fisher A; Yin JA
    Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-brain barrier.
    Takata F; Dohgu S; Yamauchi A; Sumi N; Nakagawa S; Naito M; Tsuruo T; Shuto H; Kataoka Y
    Cell Mol Neurobiol; 2007 May; 27(3):317-28. PubMed ID: 17192829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
    Van de Vrie W; Gheuens EE; Durante NM; De Bruijn EA; Marquet RL; Van Oosterom AT; Eggermont AM
    J Cancer Res Clin Oncol; 1993; 119(10):609-14. PubMed ID: 8101524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein efflux pump expression and activity in Calu-3 cells.
    Hamilton KO; Backstrom G; Yazdanian MA; Audus KL
    J Pharm Sci; 2001 May; 90(5):647-58. PubMed ID: 11288109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
    J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cyclosporin A administration on the biodistribution and multipinhole muSPECT imaging of [123I]R91150 in rodent brain.
    Blanckaert P; Burvenich I; Staelens S; De Bruyne S; Moerman L; Wyffels L; De Vos F
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):446-53. PubMed ID: 18985346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.
    van der Sandt IC; Gaillard PJ; Voorwinden HH; de Boer AG; Breimer DD
    Pharm Res; 2001 May; 18(5):587-92. PubMed ID: 11465412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of cyclosporin A on p-glycoprotein function in peripheral nerves of mice treated with doxorubicin and vinblastine.
    Saito T; Zhang ZJ; Ohtsubo T; Noda I; Tokuriki M; Shibamori Y; Yamamoto T; Saito H
    Acta Otolaryngol; 2004 Apr; 124(3):313-7. PubMed ID: 15141761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.
    Zhang X; Xie Y; Jin Y; Hou X; Ye L; Lou J
    Drug Deliv; 2004; 11(5):301-9. PubMed ID: 15742555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A.
    Saito T; Zhang ZJ; Tokuriki M; Shibamori Y; Yamamoto T; Noda I; Ohtsubo T; Saito H
    Acta Otolaryngol; 2001 Oct; 121(7):787-93. PubMed ID: 11718240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.
    Volk HA; Burkhardt K; Potschka H; Chen J; Becker A; Löscher W
    Neuroscience; 2004; 123(3):751-9. PubMed ID: 14706787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.
    Sonneveld P; Schoester M; de Leeuw K
    J Clin Oncol; 1994 Aug; 12(8):1584-91. PubMed ID: 7518859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier.
    Doze P; Van Waarde A; Elsinga PH; Hendrikse NH; Vaalburg W
    Synapse; 2000 Apr; 36(1):66-74. PubMed ID: 10700027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter.
    Seebacher NA; Lane DJ; Jansson PJ; Richardson DR
    J Biol Chem; 2016 Feb; 291(8):3796-820. PubMed ID: 26601947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase.
    Lu L; Leonessa F; Clarke R; Wainer IW
    Mol Pharmacol; 2001 Jan; 59(1):62-8. PubMed ID: 11125025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.